Skip to main content

MACKENZIE FINANCIAL CORP

Position in BBIO — BridgeBio Pharma, Inc.

CIK 919859 TORONTO ONTARIO, A6

Position in BBIO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$22,227,811
+$14,288,601 QoQ
Shares Held
298,440
+179.1% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#86
of 462 holders
Holding Since
Jun 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MACKENZIE FINANCIAL CORP holds $497,470,026 across 59 Biotechnology names. BBIO ranks #5 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 BBIO
BridgeBio Pharma, Inc.
This page
298,440 $22,227,811

All Filings in BBIO

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,227,811 298,440
2026-03-31 $7,939,210 106,911
2025-12-31 $4,168,322 54,495
2025-09-30 $2,599,441 50,047
2025-06-30 $1,225,880 28,390
2025-03-31 $660,840 19,116
2024-12-31 $260,817 9,505
2024-09-30 $226,924 8,913
2024-03-31 $216,192 6,992
2023-12-31 $282,267 6,992
2021-09-30 $294,202 6,277
2021-06-30 $222,625 3,652